The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Activated fibroblasts in cancer: Perspectives and challenges
Open accessAbstract
Activated fibroblasts in tumors or cancer-associated fibroblasts (CAFs) have become a popular research area over the past decade. As important players in many aspects of tumor biology, with functions ranging from collagen deposition to immunosuppression, CAFs have been the target of clinical and pre-clinical studies that have revealed their potential pro- and anti-tumorigenic dichotomy. In this review, we describe the important role of CAF in the tumor microenvironment, the technological advances that made these discoveries possible and we detail the models that are currently available for CAF investigation. Additionally, we present evidence to support the value of encompassing CAF investigation as a future therapeutic avenue alongside immune and cancer cells while highlighting the challenges that must be addressed for the successful clinical translation of new findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–215 of 215
Deconstructing tumor heterogeneity: the stromal perspective
Vickman, R. E., Faget, D. V., Beachy, P. A., Beebe, D. J., Bhowmick, N. A., Cukierman, E., Deng, W.-M., Granneman, J. G., Hildesheim, J., Kalluri, R., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27736 · Cited by 45
Self-citationShani, O., Raz, Y., Monteran, L., Scharff, Y., Levi-Galibov, O., Megides, O., Shacham, H., Cohen, N., Silverbush, D., Avivi, C., et al. (2021) · eLife · doi:10.7554/elife.60745 · Cited by 44
Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer
Sherman, M. H., & di Magliano, M. P. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-035400 · Cited by 42
Tejchman, A., Lamerant‐Fayel, N., Jacquinet, J., Bielawska‐Pohl, A., Mleczko‐Sanecka, K., Grillon, C., Chouaı̈b, S., Ugorski, M., & Kiéda, C. (2017) · Oncotarget · doi:10.18632/oncotarget.16311 · Cited by 38
Generation and characterization of PDGFR α‐ GFPC re ER t2 knock‐In mouse line
Miwa, H., & Era, T. (2015) · genesis · doi:10.1002/dvg.22853 · Cited by 36
Halperin, C., Hey, J., Weichenhan, D., Stein, Y., Mayer, S., Lutsik, P., Plass, C., & Scherz‐Shouval, R. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0209 · Cited by 35
Shin, J., Park, J., Park, I., & Lee, H.-M. (2015) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2015.29.4221 · Cited by 33
Cancer stemness in bone marrow micrometastases of human breast cancer
Kuo, M. C., Kothari, A. N., Kuo, P. C., & Mi, Z. (2017) · Surgery · doi:10.1016/j.surg.2017.07.027 · Cited by 32
Lin, C., & Korc, M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.008 · Cited by 31
Shaashua, L., Mayer, S., Lior, C., Lavon, H., Novoselsky, A., & Scherz‐Shouval, R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.587697 · Cited by 25
Analysis of transcriptional modules during human fibroblast ageing
Lee, Y., & Shivashankar, G. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-76117-y · Cited by 25
Metabolic Asymmetry in Cancer: A “Balancing Act” that Promotes Tumor Growth
Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.021 · Cited by 21
TP53 upregulates α‑smooth muscle actin expression in tamoxifen‑resistant breast cancer cells
Kim, S., You, D., Jeong, Y., Yu, J., Kim, S. C., Nam, S. J., & Lee, J. E. (2018) · Oncology Reports · doi:10.3892/or.2018.6910 · Cited by 16
Bauer, J. I., Emon, B., Staudacher, J. J., Thomas, A. L., Zessner‐Spitzenberg, J., Mancinelli, G. E., Krett, N. L., Saif, M. T. A., & Jung, B. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-64239-2 · Cited by 11
A cell circuit approach to dissect fibroblast-macrophage interactions in the tumor microenvironmentPreprint
Mayer, S., Milo, T., Isaacson, A., Halperin, C., Miyara, S., Stein, Y., Pevsner‐Fischer, M., Tzahor, E., Alon, U., & Scherz‐Shouval, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.17.516850 · Cited by 5
Cited by
The cancer-immunity cycle: Indication, genotype, and immunotype
Mellman, I., Chen, D. S., Powles, T., & Turley, S. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.011 · Cited by 953
Therapeutic developments in pancreatic cancer
Hu, Z. I., & O’Reilly, E. M. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00840-w · Cited by 413
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics
Prakash, J., & Shaked, Y. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0002 · Cited by 366
Cords, L., Engler, S., Haberecker, M., Rüschoff, J. H., Moch, H., de Souza, N., & Bodenmiller, B. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.021 · Cited by 304
Metadata
- Authors
- Caligiuri, G., & Tuveson, D. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 41
- Issue
- 3
- Pages
- 434-449
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W4324046116
- Cited by
- 424
- References
- 215
- FWCI
- 44.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.